Les Laboratoires Servier SAS - Product Pipeline Review - 2015

  • ID: 3280655
  • Company Profile
  • 62 pages
  • Global Markets Direct
  • Laboratoires Servier
1 of 4
Les Laboratoires Servier SAS - Product Pipeline Review - 2015

Summary

This, ‘Les Laboratoires Servier SAS - Product Pipeline Review - 2015’, provides an overview of the Les Laboratoires Servier SAS’s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Les Laboratoires Servier SAS’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

This report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from This proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by This team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of Les Laboratoires Servier SAS including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Les Laboratoires Servier SAS’s human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement
- Latest news and deals relating to the Les Laboratoires Servier SAS’s pipeline products

Reasons to buy

- Evaluate Les Laboratoires Servier SAS’s strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Les Laboratoires Servier SAS in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Les Laboratoires Servier SAS’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Les Laboratoires Servier SAS and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Les Laboratoires Servier SAS
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of Les Laboratoires Servier SAS and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues
READ MORE
Note: Product cover images may vary from those shown
2 of 4
List of Tables
List of Figures
Les Laboratoires Servier SAS Snapshot
Les Laboratoires Servier SAS Overview
Key Information
Key Facts
Les Laboratoires Servier SAS - Research and Development Overview
Key Therapeutic Areas
Les Laboratoires Servier SAS - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
Pipeline Products - Combination Treatment Modalities
Pipeline Products - Partnered Products
Partnered Products/Combination Treatment Modalities
Les Laboratoires Servier SAS - Pipeline Products Glance
Les Laboratoires Servier SAS - Late Stage Pipeline Products
Pre-Registration Products/Combination Treatment Modalities
Phase III Products/Combination Treatment Modalities
Les Laboratoires Servier SAS - Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Phase I Products/Combination Treatment Modalities
Les Laboratoires Servier SAS - Early Stage Pipeline Products
Preclinical Products/Combination Treatment Modalities
Discovery Products/Combination Treatment Modalities
Les Laboratoires Servier SAS - Drug Profiles
(perindopril + amlodipine besylate)
Product Description
Mechanism of Action
R&D Progress
gevokizumab
Product Description
Mechanism of Action
R&D Progress
ivabradine
Product Description
Mechanism of Action
R&D Progress
lucitanib
Product Description
Mechanism of Action
R&D Progress
S-38844
Product Description
Mechanism of Action
R&D Progress
S-47445
Product Description
Mechanism of Action
R&D Progress
S-49076
Product Description
Mechanism of Action
R&D Progress
S-055746
Product Description
Mechanism of Action
R&D Progress
Small Molecule to Inhibit Mcl-1 for Cancer
Product Description
Mechanism of Action
R&D Progress
Drugs to Inhibit Insulin-Regulated AminoPeptidase for Alzheimer’s Disease
Product Description
Mechanism of Action
R&D Progress
Monoclonal Antibodies for Cancer
Product Description
Mechanism of Action
R&D Progress
Drugs for Breast Cancer
Product Description
Mechanism of Action
R&D Progress
Les Laboratoires Servier SAS - Pipeline Analysis
Les Laboratoires Servier SAS - Pipeline Products by Target
Les Laboratoires Servier SAS - Pipeline Products by Route of Administration
Les Laboratoires Servier SAS - Pipeline Products by Molecule Type
Les Laboratoires Servier SAS - Pipeline Products by Mechanism of Action
Les Laboratoires Servier SAS - Recent Pipeline Updates
Les Laboratoires Servier SAS - Dormant Projects
Les Laboratoires Servier SAS - Discontinued Pipeline Products
Discontinued Pipeline Product Profiles
agomelatine
terutroban
Les Laboratoires Servier SAS - Company Statement
Les Laboratoires Servier SAS - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
Les Laboratoires Servier SAS, Key Information
Les Laboratoires Servier SAS, Key Facts
Les Laboratoires Servier SAS - Pipeline by Indication, 2015
Les Laboratoires Servier SAS - Pipeline by Stage of Development, 2015
Les Laboratoires Servier SAS - Monotherapy Products in Pipeline, 2015
Les Laboratoires Servier SAS - Combination Treatment Modalities in Pipeline, 2015
Les Laboratoires Servier SAS - Partnered Products in Pipeline, 2015
Les Laboratoires Servier SAS - Partnered Products/ Combination Treatment Modalities, 2015
Les Laboratoires Servier SAS - Pre-Registration, 2015
Les Laboratoires Servier SAS - Phase III, 2015
Les Laboratoires Servier SAS - Phase II, 2015
Les Laboratoires Servier SAS - Phase I, 2015
Les Laboratoires Servier SAS - Preclinical, 2015
Les Laboratoires Servier SAS - Discovery, 2015
Les Laboratoires Servier SAS - Pipeline by Target, 2015
Les Laboratoires Servier SAS - Pipeline by Route of Administration, 2015
Les Laboratoires Servier SAS - Pipeline by Molecule Type, 2015
Les Laboratoires Servier SAS - Pipeline Products by Mechanism of Action, 2015
Les Laboratoires Servier SAS - Recent Pipeline Updates, 2015
Les Laboratoires Servier SAS - Dormant Developmental Projects,2015
Les Laboratoires Servier SAS - Discontinued Pipeline Products, 2015
Les Laboratoires Servier SAS, Other Locations
Les Laboratoires Servier SAS, Subsidiaries

List of Figures
Les Laboratoires Servier SAS - Pipeline by Top 10 Indication, 2015
Les Laboratoires Servier SAS - Pipeline by Stage of Development, 2015
Les Laboratoires Servier SAS - Monotherapy Products in Pipeline, 2015
Les Laboratoires Servier SAS - Partnered Products in Pipeline, 2015
Les Laboratoires Servier SAS - Pipeline by Top 10 Target, 2015
Les Laboratoires Servier SAS - Pipeline by Top 10 Route of Administration, 2015
Les Laboratoires Servier SAS - Pipeline by Top 10 Molecule Type, 2015
Les Laboratoires Servier SAS - Pipeline Products by Top 10 Mechanism of Action, 2015
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
Note: Product cover images may vary from those shown
Adroll
adroll